Session Details
[Pe-053]English Poster Session 053 Neuroimmunology (MS:Clinical study)
Sat. May 24, 2025 1:30 PM - 2:50 PM JST
Sat. May 24, 2025 4:30 AM - 5:50 AM UTC
Sat. May 24, 2025 4:30 AM - 5:50 AM UTC
ポスター会場(大阪国際会議場3F イベントホール)
Chairs: Masaaki Niino(Department of Clinical Research, Hokkaido Medical Center, Japan), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University, Japan)
[Pe-053-1]Alteration of JC virus index in patients with multiple sclerosis using disease modifying drugs
Takahiro Nakayama1, Reiko Kawasaki2 (1.Department of neurology, division of neuromuscular diseases, Yokohama Rosai Hospital, Japan, 2.Department of neurology, Yokohama Rosai Hospital, Japan)
[Pe-053-2]Structure Equation Modeling Reveals Reward System Contributes to Fatigue in Multiple Sclerosis
Shu Umezawa1, Yasuko Tatewaki2, Yuki Matsumoto3, Naohiro Sakamoto1, Mizuki Otomo1, Naoki Yamamoto1, Naoya Yamazaki1, Chihiro Namatame3, Hirohiko Ono3, Kimihiko Kaneko3, Yoshiki Takai3, Shuhei Nishiyama3, Hiroshi Kuroda4,5, Juichi Fujimori6, Kazuo Fujihara4,5, Tatsuro Misu3, Yasuyuki Taki2, Masashi Aoki3 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan, 2.Department of Aging Research and Geriatric Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan, Japan, 3.Department of Neurology, Tohoku University Hospital, Sendai, Japan, Japan, 4.Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Fukushima, Japan, Japan, 5.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan, Japan, 6.Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, Japan)
[Pe-053-3]Neuroimaging and HLA profiles of a novel nodal ATP1A2/3 antibody-positive demyelinating disease
Yuri Nakamura1,2,3, Xu Zhang2, Ayako Sakoda1,2, Mikio Mitsuishi2, Miho Ushijima2, Guzailiayi Maimaitijiang2, Tomohiro Imamura2,3, Jun-ichi Kira1,2,3 (1.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Japan, 2.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Japan, 3.School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan)
[Pe-053-4]Three cases of multiple sclerosis presenting with palmoplantar pustulosis while receiving ofatumumab
Taichi Nomura1,2, Hiroaki Yaguchi1,2, Hisashi Uwatoko1,2, Ken Muramatsu3, Kentaro Izumi3, Hideyuki Ujiie3, Atsushi Kawashima1, Toshiyuki Fukazawa1, Ichiro Yabe2 (1.Sapporo Neurology Hospital, Japan, 2.Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan, 3.Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan)
[Pe-053-5]Analysis of white blood cell subset changes induced by DMD for MS in routine laboratory testing
Mizuki Otomo1, Tatsuro Misu1, Naohiro Sakamoto1, Naoki Yamamoto1, Naoya Yamazaki1, Shu Umezawa1, Chihiro Namatame1, Yuki Matsumoto1, Hirohiko Ono1, Kaneko Kimihiko1, Yoshiki Takai1, Shuhei Nishiyama1, Hiroshi Kuroda2,3, Toshiyuki Takahashi4, Kazuo Fujihara2,3, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Multiple Sclerosis & Neuromyelitis Optica Center, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 4.Department of Neurology, National Hospital Organization Yonezawa National Hospital, Japan)
[Pe-053-6]The efficacy of Cladribine in real clinical practice
Aleksandr Peshkin, Sergey Kotov, Georgiy Toniya, Ahmed Eltayoury (Moscow Regional Research and Clinical Institute, Russia)
[Pe-053-7]Exploring Nutritional Profiles in MS, NMOSD, and MOGAD: Insights from our hospital
Punchika Kosiyakul, Teerawat Koosirirat, Natnasak Apiraksattayakul, Sasitorn Siritho, Tatchaporn Ongphichetmetha, Kusuma Chaiyasoot, Naraporn Prayoonwiwat, Jiraporn Jitprapaikulsan (Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand)